Replies to post #571067 on NorthWest Biotherapeutics Inc (NWBO)

[hoffmann6383]

great points atl

[Poor Man -]

They purchase the company and its future cash flows like with any business. You literally answered your own question below. But to your point, and we’re aligned on this, then maybe Linda Powers will just hand over the business to NWBO for a nominal value, since NWBO shareholders have already funded and own everything, and the contracts are all between NWBO and Toucan, controlled by the same person. That would in fact be the correct approach.

So I expect you’ll join the lawsuit if NWBO shareholders are asked to pay Toucan for the shares of Advent?

Since as you say, NWBO already owns and controls everything. Right?

Advent’s primary assets are its people, and its contract with NWBio to manufacture DCVax. That contract is controlled by NWBio.

[dennisdave]

Advent’s primary assets are its people, and its contract with NWBio to manufacture DCVax. That contract is controlled by NWBio.

wrong. Advent's primary asset is the future granted MIA to Advent. Staff can be replaced, clients can be replaced.

[X Master]

IMO - Sawston purpose is to establish the procedures and provide a baseline for production cost of DCVax-L. CRL is probably shadowing both. Prior to approval, NWBO and CRL will negotiate the cost for CRL's services. Needless to say FlaskWorks has been integrated into this process.